Bauer H, Negishi C, Weinmann H J
Research Laboratories, Schering AG Berlin, Germany.
Invest Radiol. 1994 Aug;29(8):752-7. doi: 10.1097/00004424-199408000-00004.
The potential of gadolinium compounds (Gd-ethoxybenzyl-DTPA [Gd-EOB-DTPA], gadopentetate dimeglumine [Gd-DTPA], and Gd-chloride [GdCl3]) to enhance the signals from intracellular phosphorus-31 nuclei in the liver was investigated.
After intravenous administration of Gd-EOB-DTPA, Gd-DTPA, and GdCl3 to rats, liver phosphorus metabolites (inorganic phosphate [Pi], phosphomonoester [PME], and adenosine triphosphate [ATP]) were measured by phosphorus-31 magnetic resonance spectroscopy (MRS). The dose of each compound was 0.2 mmol Gd/kg. Saline was used as a control.
The intensities of the phosphorus metabolite signals in the liver showed only minor changes after administration of Gd-DTPA and GdCl3, but increased after Gd-EOB-DTPA. The signals of Pi and PME were enhanced more than those of ATP. The alpha peak of ATP increased by 21.7%, Pi by 61.2%, and PME by 49.2%.
The signal intensities of the phosphorus metabolites in the liver were not influenced by GdCl3. Using Gd-DTPA, only a slight enhancement could be detected. The greatest enhancement was observed with Gd-EOB-DTPA, which has access to the phosphorus metabolites within the hepatocytes. The injection of Gd-EOB-DTPA results in better detectability of the Pi signal.
研究钆化合物(钆乙氧基苄基二乙三胺五乙酸[Gd-EOB-DTPA]、钆喷酸葡胺[Gd-DTPA]和氯化钆[GdCl3])增强肝脏细胞内磷-31核信号的潜力。
给大鼠静脉注射Gd-EOB-DTPA、Gd-DTPA和GdCl3后,通过磷-31磁共振波谱(MRS)测量肝脏磷代谢物(无机磷酸盐[Pi]、磷酸单酯[PME]和三磷酸腺苷[ATP])。每种化合物的剂量为0.2 mmol钆/千克。使用生理盐水作为对照。
注射Gd-DTPA和GdCl3后,肝脏中磷代谢物信号强度仅出现轻微变化,但注射Gd-EOB-DTPA后信号增强。Pi和PME的信号增强幅度大于ATP。ATP的α峰增加了21.7%,Pi增加了61.2%,PME增加了49.2%。
肝脏中磷代谢物的信号强度不受GdCl3影响。使用Gd-DTPA时,仅能检测到轻微增强。使用Gd-EOB-DTPA观察到最大增强效果,其能够进入肝细胞内的磷代谢物。注射Gd-EOB-DTPA可提高Pi信号的可检测性。